Renal Cell Carcinoma in a Renal Allograft Successful Treatment With 5 Year Follow-Up

Clinical Medicine and Research - United States
doi 10.3121/cmr.2.3.151
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Marshfield Clinic Research Foundation

Related search

Outcome of Tacrolimus Conversion Therapy for Renal Allograft Rejection: 5-Year Follow-Up

Transplantation Proceedings
SurgeryTransplantation
1999English

Prognostic Value of Downregulated 5-Hydroxymethylcytosine Expression in Renal Cell Carcinoma: A 10 Year Follow-Up Retrospective Study

Journal of Cancer
Oncology
2020English

Renal Vein Leiomyosarcoma and Renal Cell Carcinoma Presenting Together: A Case Report and Discussion on the Follow Up.

Canadian Urological Association Journal
Urology
2015English

Nivolumab in Treatment of Renal Cell Carcinoma During Renal Replacement Therapy

Oncology in Clinical Practice
Oncology
2019English

Renal Involvement in a Patient With Cobalamin a Type (cblA) Methylmalonic Aciduria: A 42-Year Follow-Up

Molecular Genetics and Metabolism
GeneticsMolecular BiologyBiochemistryEndocrinologyMetabolismDiabetes
2013English

Tivozanib in the Treatment of Renal Cell Carcinoma

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2013English

Renal Cell Carcinoma

World Journal of Urology
Urology
2016English

Five-Year Experience With Tacrolimus Rescue for Renal Allograft Rejection

Transplantation Proceedings
SurgeryTransplantation
1997English

A Case of Sarcomatoid Renal Cell Carcinoma With Osseous Metaplasia and Papillary Renal Cell Carcinoma Metastasis

Clinical Pathology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy